Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Tocris Bioscience™ SGC 0946

Click to view available options
Quantity:
2 mg
Description
SGC 0946 is a highly potent DOT1L methyltransferase inhibitor (Kd = 0.06 nM, IC50 = 0.3 nM in a radioactive assay); blocks H3K79 methylation in A431 cells and MCF10A cells. Inactive at 12 histone methyltransferases and DNMT1. Selectively kills cells transformed with the MLL-AF9 fusion oncogene in an in vitro model of leukemia; lowers levels of MLL target genes HOXA9 and Meis1.
To request the negative control for SGC0946, please fill out the SGC0649 request form on the SGC website.
Specifications
Specifications
| Chemical Name or Material | 1-[3-[[[(2 R,3 S,4 R,5 R)-5-(4-Amino-5-bromo-7 H-pyrrolo[2,3-d]pyrimidin-7-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl](isopropyl)amino]propyl]-3-[4-(2,2-dimethylethyl)phenyl]urea |
| CAS | 1561178-17-3 |
| Quantity | 2 mg |
| Target | Lysine Methyltransferase Inhibitors |
| Molecular Formula | C28H40BrN7O4 |
| Purity | 99% |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction